Prospects for the Use of Artificial Intelligence in Personalized Medicine, Pharmaceutical Design and Education
DOI:
https://doi.org/10.53933/sspmpm.v5i2.182Keywords:
artificial intelligence, pharmaceutical design, development of new drugs, personalized medicine, clinical trials, pharmacotherapy, ethical aspects, regulatory requirementsAbstract
The article reviews modern approaches to the use of artificial intelligence in personalized medicine, pharmaceutical design and education, in particular in the pharmaceutical industry, in the processes of search, development, new drugs, personalization of pharmacotherapy and in the education of specialists in these processes. An analysis of the main areas of application of artificial intelligence, its advantages and challenges, as well as the impact on pharmaceutical design in the creation of new drugs is carried out. Special attention is paid to the role of artificial intelligence in personalized medicine, prediction of clinical and pharmacological properties, optimization of clinical trials. Ethical and regulatory aspects of integrating artificial intelligence into medical and pharmaceutical education are considered. Prospects for further development and improvement of the implementation of artificial intelligence in medicine, pharmaceutical design and education are identified. The potential for artificial intelligence to accelerate drug discovery, reduce costs, and enhance treatment precision through real-time analysis of vast datasets is particularly highlighted. Additionally, educational curricula incorporating artificial intelligence-based simulations and virtual reality tools for training future pharmaceutical professionals are explored.
References
Lavoshnik O., Gryzodoub O., Diachenko L. et al. (2025). State Pharmacopoeia of Ukraine and Pharmaceutical Law: State Quality Standard for Medicines for Standardization and Quality Control During Circulation in Healthcare and Pharmacy Sectors. SSP Modern Pharmacy and Medicine. 2025. Vol.5. No.1. P.1-20. URL: https://doi.org/10.53933/sspmpm.v5i1.176 DOI: https://doi.org/10.53933/sspmpm.v5i1.176
Shapovalova V., Shapovalov V., Osyntseva А. et al. Organization of the Pharmaceutical Business, Industrial Pharmacy and Forensic Pharmacy Concerning the Competences of Quality Management During the Circulation of Medical Products: GxP Standards. Actual Problems of Medicine and Pharmacy. 2022. Vol. 3. No 2. P. 1-20. DOI: https://doi.org/10.52914/apmp.v3i2.44 DOI: https://doi.org/10.52914/apmp.v3i2.44
Shapovalov V., Veits O. Medical and Pharmaceutical Law in Erasmus+: Study of the Disciplines by Medical Students as a Basis for Training of Healthcare Professionals in Prevention of Medical Errors and Crimes. SSP Modern Law and Practice. 2024. Vol. 4. 4. Р. 1-17. DOI: https://doi.org/10.53933/sspmlp.v4i4.169 DOI: https://doi.org/10.53933/sspmlp.v4i4.169
Shapovalova V. The ICD-11 For the Twenty-First Century: The First View from The Organizational, Legal, Clinical and Pharmacological Aspects. SSP Modern Pharmacy and Medicine. 2022. Vol. 2. No 1. Р. 1-13. DOI: https://doi.org/10.53933/sspmpm.v2i1.37 DOI: https://doi.org/10.53933/sspmpm.v2i1.37
Shapovalova V. The main changes in the ICD-11. Preprint. Version 1. 2024. DOI: https://doi.org/10.61829/7fvvxa57. DOI: https://doi.org/10.61829/7fvvxa57
Shapovalov V.V., Gudzenko A.O., Shapovalova V.O. et al. Clinical and pharmacological, classification and legal, nomenclature and legal distribution of medicines for pharmacotherapy of depression among combatants (F32-33). Health of Society. 2021. Vol. 7 No. 4. P. 181-186. DOI: https://doi.org/10.22141/2306-2436.7.4.2018.148361 DOI: https://doi.org/10.22141/2306-2436.7.4.2018.148361
Shapovalov V. Multidisciplinary study of medical errors in the system of legal relations between "Doctor-Patient-Pharmacist-Advocate" during the circulation of drugs. SSP Modern Pharmacy and Medicine. 2023. Vol. 3. No. 2. P. 1-11. DOI: https://doi.org/10.53933/sspmpm.v3i2.88 DOI: https://doi.org/10.53933/sspmpm.v3i2.88
Nevzghoda O., Shapovalov V., Osyntseva A. et al. Codeines medicine: ABC/VED analysis, effectiveness and rationality of application. Annals of Mechnikov Institute. 2024. No.4. P.29–34. URL: https://doi.org/10.5281/zenodo.14275098
Shapovalova V. Forensic and pharmaceutical risks in the organization of pharmacotherapy of covid, post-covid and long-covid disorders. COVID-19 and vaccination practice standards. SSP Modern Pharmacy and Medicine. 2022. Vol. 2. No. 4. P. 1–24. URL: https://doi.org/10.53933/sspmpm.v2i4.69 DOI: https://doi.org/10.53933/sspmpm.v2i4.69
Gryzodoub O., Shapovalov V. Quality Systems in Pharmacy: Multidisciplinary Context of the State Pharmacopoeia of Ukraine. SSP Modern Law and Practice. 2023. Vol. 3. No. 1, P. 1-23. DOI: https://doi.org/10.53933/sspmlp.v3i1.81 DOI: https://doi.org/10.53933/sspmlp.v3i1.81
Vora L.K., Gholap A.D., Jetha K. et al. Artificial Intelligence in Pharmaceutical Technology and Drug Delivery Design. Pharmaceutics. 2023. Vol.10. Iss.15(7). P.1916. DOI: 10.3390/pharmaceutics15071916. URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10385763/ DOI: https://doi.org/10.3390/pharmaceutics15071916
Saha A., Singh I. Harnessing the Power of Artificial Intelligence in Pharmaceuticals: Current Trends and Future Prospects. Intell. Pharm. 2024. DOI: 10.1016/j.ipha.2024.12.001 DOI: https://doi.org/10.1016/j.ipha.2024.12.001
Yadav P., Rastogi V., Yadav A. et al. Artificial intelligence: A promising tool in diagnosis of respiratory diseases. Intell. Pharma. 2024. DOI: 10.1016/j.ipha.2024.05.002. URL: https://doi.org/10.1016/j.ipha.2024.05.002 DOI: https://doi.org/10.1016/j.ipha.2024.05.002
Taherdoost H., Ghofrani A. AI's role in revolutionizing personalized medicine by reshaping pharmacogenomics and drug therapy. Intell. Pharma. 2024 DOI: 10.1016/j.ipha.2024.08.005. URL: https://doi.org/10.1016/j.ipha.2024.08.005 DOI: https://doi.org/10.1016/j.ipha.2024.08.005
Miah R. Artificial intelligence in anti-dengue drug development. Intell. Pharma. 2024. DOI: 10.1016/j.ipha.2024.01.006. URL: https://doi.org/10.1016/j.ipha.2024.01.006 DOI: https://doi.org/10.1016/j.ipha.2024.01.006
Unleashing the potential of Artificial Intelligence in medicine: transforming diagnostics and treatment. Ukrainian Association of Development IT Medicine. 01.09.2023. URL: https://www.esemi.org/ai_med/
Nikitha B.S., Roopa K., Kynshi S.L. et al. Artificial intelligence and internet influence on drug utilization: Exploring self-medication trends in South Indian pharmacy students. International Journal of Pharmacy. 2024. DOI: 10.1016/j.ipha.2024.06.001 DOI: https://doi.org/10.1016/j.ipha.2024.06.001
EFPIA. EFPIA position on the use of artificial intelligence in the medicinal product lifecycle. October 2024. URL: https://www.efpia.eu/media/tzeavw1t/efpia-position-on-the-use-of-artificial-intelligence-in-the-medicinal-product-lifecycle.pdf
European Medicines Agency. The use of Artificial Intelligence (AI) in the medicinal product lifecycle. URL: https://www.ema.europa.eu/en/use-artificial-intelligence-ai-medicinal-product-lifecycle.
European Medicines Agency. Reflection paper on the use of Artificial Intelligence (AI) in the medicinal product lifecycle. September 9, 2024. EMA/CHMP/CVMP/83833/2023. URL: https://www.ema.europa.eu/en/documents/scientific-guideline/reflection-paper-use-artificial-intelligence-ai-medicinal-product-lifecycle_en.pdf.
Drug Development & Delivery. Artificial intelligence: Accelerating drug discovery and development – The AI revolution is here. URL: https://drug-dev.com/artificial-intelligence-accelerating-drug-discovery-development-the-ai-revolution-is-here/.
Roche. Artificial intelligence and machine learning: Revolutionising drug discovery and transforming patient care. URL: https://www.roche.com/stories/ai-revolutionising-drug-discovery-and-transforming-patient-care
The TED-Ed Student Talks program provides free, customizable events for educators to support their students in discovering, developing, and sharing their ideas with each other and the world. TedEd. URL: https://ed.ted.com/student_talks?utm_medium=website_sailthru&utm_source=talk_exitintent&utm_campaign=ted-ed-apps&utm_content=march15cycle
Can AI help develop new drugs? Ted. URL: https://www.ted.com/talks/aviv_regev_can_ai_help_develop_new_medicines
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Viktoria Dovzhuk , Liudmyla Konovalova , Natela Dovzhuk, Serhii Konovalov, Liudmyla Konoshevych, Nataliia Motorna
This work is licensed under a Creative Commons Attribution 4.0 International License.
